Tumor metabolic volume by <sup>18</sup>F-FDG-PET as a prognostic predictor of first-line pembrolizumab for NSCLC patients with PD-L1 ≥ 50.

Sci Rep · 2020 · PMC7490347 · PMID 32929123

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Only high MTV was a marginally significant factor for predicting worse OS, but not PFS (Table 3 ) and was identified as an independent factor linked to worse OS in multivariate analysis (Table 4 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.